Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.
暂无分享,去创建一个
R. Jenq | M. V. D. van den Brink | C. Lezcano | Ya-Yuan Fu | G. Murphy | J. Dudakov | A. Hanash | L. Young | A. M. Holland | J. Tsai | Chen Liu | K. Argyropoulos | U. Rao | E. Velardi | F. Kreines | Il-Kang Na | A. Lazrak | Sophie R. Lieberman | Y. Shono | O. M. Smith | N. Yim | Salma Youssef | Odette M. Smith | A. Holland | Sophie Lieberman
[1] S. Biswal,et al. Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice , 2017, Molecular and Cellular Biology.
[2] K. Liby,et al. Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H2O2 in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[3] Hongye Liu,et al. Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. , 2016, JCI insight.
[4] A. Metidji,et al. Helios Controls a Limited Subset of Regulatory T Cell Functions , 2016, The Journal of Immunology.
[5] T. Holderried,et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios , 2015, Science.
[6] S. Reddy,et al. T Lymphocyte-Specific Activation of Nrf2 Protects from AKI. , 2015, Journal of the American Society of Nephrology : JASN.
[7] F. Jiang,et al. The antioxidant compound tert-butylhydroquinone activates Akt in myocardium, suppresses apoptosis and ameliorates pressure overload-induced cardiac dysfunction , 2015, Scientific Reports.
[8] D. Sinclair,et al. Aging-like Phenotype and Defective Lineage Specification in SIRT1-Deleted Hematopoietic Stem and Progenitor Cells , 2014, Stem cell reports.
[9] O. Fardel,et al. Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone. , 2014, Free radical biology & medicine.
[10] G. Altan-Bonnet,et al. A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity. , 2014, Cancer discovery.
[11] Zhiyong Guo,et al. Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. , 2013, International journal of clinical and experimental pathology.
[12] C. Ebens,et al. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. , 2013, The Journal of clinical investigation.
[13] Koichi Takahashi,et al. Nrf2 regulates haematopoietic stem cell function , 2013, Nature Cell Biology.
[14] D. MacEwan,et al. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. , 2012, Blood.
[15] Parmvir K Bahia,et al. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity , 2012, Journal of neurochemistry.
[16] M. Sporn,et al. NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.
[17] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[18] C. Klaassen,et al. Th2 Skewing by Activation of Nrf2 in CD4+ T Cells , 2012, The Journal of Immunology.
[19] M. Horowitz,et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. , 2012, Blood.
[20] W. Wilson,et al. Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma , 2011, Clinical Cancer Research.
[21] D. MacEwan,et al. High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors. , 2011, Cancer research.
[22] Mario Roederer,et al. Interpretation of cellular proliferation data: Avoid the panglossian , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[23] R. Blasberg,et al. Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo. , 2010, Blood.
[24] DelindaA . Johnson,et al. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[25] Christopher G. King,et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. , 2010, The Journal of clinical investigation.
[26] C. B. Pickett,et al. The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.
[27] A. Kong,et al. Molecular mechanisms of Nrf2‐mediated antioxidant response , 2009, Molecular carcinogenesis.
[28] P. Wong,et al. Dual roles of Nrf2 in cancer. , 2008, Pharmacological research.
[29] C. Contag,et al. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. , 2008, Blood.
[30] M. Bachmann,et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. , 2008, Blood.
[31] M. Tanimoto,et al. FTY720 enhances the activation‐induced apoptosis of donor T cells and modulates graft‐versus‐host disease , 2007, European journal of immunology.
[32] M. V. D. van den Brink,et al. Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. , 2006, Blood.
[33] M. V. D. van den Brink,et al. CCR2 is required for CD8-induced graft-versus-host disease. , 2005, Blood.
[34] C. Contag,et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. , 2005, Blood.
[35] W. Mitzner,et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice , 2005, The Journal of experimental medicine.
[36] A. Hanash,et al. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. , 2005, Blood.
[37] J. Mora,et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues , 2005, The Journal of experimental medicine.
[38] J. Serody,et al. In vivo imaging of graft-versus-host-disease in mice. , 2004, Blood.
[39] A. Greenberg,et al. LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease , 2004 .
[40] B. Malissen,et al. Selective Generation of Gut Tropic T Cells in Gut-associated Lymphoid Tissue (GALT) , 2003, The Journal of experimental medicine.
[41] C. Fathman,et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.
[42] Wolfgang Weninger,et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells , 2003, Nature.
[43] E. Pamer,et al. Feedback regulation of pathogen-specific T cell priming. , 2003, Immunity.
[44] M. Kamm,et al. Intestinal dendritic cells increase T cell expression of α4β7 integrin , 2002 .
[45] P. Marrack,et al. Linkage analysis of variations in CD4:CD8 T cell subsets between C57BL/6 and DBA/2 , 2002, Genes and Immunity.
[46] E. Butcher,et al. Rapid Acquisition of Tissue-specific Homing Phenotypes by CD4+ T Cells Activated in Cutaneous or Mucosal Lymphoid Tissues , 2002, The Journal of experimental medicine.
[47] K. Kang,et al. Activation of phosphatidylinositol 3-kinase and Akt by tert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells. , 2001, Molecular pharmacology.
[48] G. Holländer,et al. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells. , 2000, Blood.
[49] C. Perreault,et al. Massive Activation-Induced Cell Death of Alloreactive T Cells With Apoptosis of Bystander Postthymic T Cells Prevents Immune Reconstitution in Mice With Graft-Versus-Host Disease , 1999 .
[50] J. Crawford,et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.
[51] Y. Kan,et al. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[52] L. Picker,et al. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. , 1993, Journal of immunology.
[53] T. Ghayur,et al. The Functional and Histological Basis for Graft‐versus‐Host‐Induced Immunosuppression , 1985, Immunological reviews.
[54] J. Sprent,et al. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.
[55] T. Seemayer,et al. Thymic involution in murine graft-versus-host reaction. Epithelial injury mimicking human thymic dysplasia. , 1977, The American journal of pathology.